Biocartis Group Ownership

Stocks . Belgium . 
Stock . Biocartis Group NV
BCART Stock  EUR 0.29  0.00  0.00%   
Biocartis Group holds a total of 93.1 Million outstanding shares. Biocartis Group NV shows 6.66 percent of its outstanding shares held by insiders and 27.71 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Biocartis Group in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Biocartis Group, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biocartis Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Biocartis Stock Ownership Analysis

About 28.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.24. Biocartis Group NV had not issued any dividends in recent years. The entity had 783:683 split on the 17th of November 2022. Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. BIOCARTIS operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 619 people. For more info on Biocartis Group NV please contact Herman Verrelst at 32 1 563 20 00 or go to https://www.biocartis.com.

Biocartis Group Outstanding Bonds

Biocartis Group issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biocartis Group NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biocartis bonds can be classified according to their maturity, which is the date when Biocartis Group NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp Bond
US235822AB96		View
Boeing Co 2196 Corp Bond
US097023DG73		View
HSBC Holdings PLC Corp Bond
US404280DR76		View
MPLX LP 4125 Corp Bond
US55336VAK61		View
MPLX LP 52 Corp Bond
US55336VAL45		View
AerCap Global Aviation Corp Bond
US00773HAA59		View

Other Information on Investing in Biocartis Stock

Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY